M. Schwamborn

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.

D. Schadendorf, B. Schilling, J. Malvehy, 2014, Journal of the National Cancer Institute.

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

D. Schadendorf, B. Schilling, R. Murali, 2014, Modern Pathology.

Melanoma differentiation trajectories determine sensitivity towards pre-existing CD8+ tumor-infiltrating lymphocytes.

D. Schadendorf, A. Roesch, A. Sucker, 2021, The Journal of investigative dermatology.

TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma

D. Schadendorf, B. Schilling, R. Murali, 2013, PloS one.

Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment

S. Haferkamp, D. Schadendorf, B. Schilling, 2018, Oncoimmunology.